Fatty Liver Disease Treatment in Dubai: MASLD Care by Dr. Ali Aldibbiat
20+ Years Clinical Experience | FRCP (London) | FRCP (Edinburgh) | PhD Researcher | FACE | Associate Professor | Jumeirah, Dubai
Fatty liver disease, now formally termed metabolic dysfunction-associated steatotic liver disease (MASLD), affects an estimated 30% of adults in Dubai and the wider UAE, making it one of the most common conditions seen in endocrinology and metabolic medicine practice. Fatty liver disease treatment in Dubai is frequently delayed because the condition causes no symptoms in its early stages, yet it can progress silently to fibrosis, cirrhosis, and liver cancer if the underlying metabolic drivers are not addressed. Dr. Ali Aldibbiat provides specialist fatty liver disease treatment in Dubai at his Jumeirah clinic with fibrosis risk stratification and a structured metabolic management plan.
Fatty liver disease (metabolic dysfunction-associated steatotic liver disease) is a progressive condition in which excess fat accumulates in the liver, affecting at least 5% of liver cells, in the absence of significant alcohol consumption. It exists on a spectrum transitioning from simple steatosis to metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, and ultimate cirrhosis.
The liver's role in fat and glucose metabolism makes it particularly vulnerable to the effects of insulin resistance. When the body's cells become resistant to insulin, the liver is exposed to higher levels of free fatty acids and develops increased fat storage.
Fatty liver disease has reached epidemic proportions globally, and Dubai's population carries a particularly high risk given the prevalence of obesity, type 2 diabetes, and sedentary lifestyle. Fatty liver disease treatment in Dubai must therefore be embedded within broader metabolic care, addressing weight, glucose control, and lipid management together rather than treating the liver in isolation.
What Causes Fatty Liver
Disease in Dubai?
Fatty liver disease treatment in Dubai begins with understanding the specific metabolic drivers present in each patient, since these determine both prognosis and the most effective treatment strategy.
Obesity and Visceral Fat
Excess visceral (abdominal) fat is the single strongest risk factor for fatty liver disease. Visceral fat is metabolically active, releasing free fatty acids and inflammatory signals directly into the portal circulation that drains into the liver, promoting fat accumulation and inflammation within liver tissue.
Type 2 Diabetes and Insulin Resistance
Up to 70% of patients with type 2 diabetes have fatty liver disease, and the relationship runs in both directions: insulin resistance promotes liver fat accumulation, while fatty liver disease itself worsens insulin resistance.
Explore Diabetes Management Protocol →
Dyslipidaemia
Elevated triglycerides and the diabetic dyslipidemia pattern (high triglycerides, low HDL) are closely associated with fatty liver disease, reflecting the shared underlying disturbance in lipid metabolism.
Explore Dyslipidemia Matrix →
Genetic and Other Factors
Certain genetic variants (PNPLA3, TM6SF2) increase susceptibility to fatty liver disease and its progression to fibrosis, independent of body weight. Polycystic ovary syndrome, hypothyroidism, and obstructive sleep apnea are also associated with increased fatty liver disease risk and should be assessed as part of a comprehensive workup.
Symptoms of Fatty Liver Disease
Fatty liver disease is frequently asymptomatic, particularly in its early stages, which is precisely why fatty liver disease treatment Dubai often begins after an incidental finding rather than a presenting complaint.
Often No Symptoms at All
The majority of patients with simple steatosis have no symptoms whatsoever. Fatty liver disease is frequently discovered incidentally on abdominal ultrasound performed for an unrelated reason or through mildly elevated liver enzymes on routine blood testing.
Fatigue & Right Upper Discomfort
Some patients report vague fatigue or a sense of fullness or mild discomfort in the right upper abdomen, where the liver is located. These symptoms are non-specific and easily attributed to other causes but, in combination with metabolic risk factors, should prompt liver assessment.
Signs of Advanced Liver Disease
In advanced fibrosis or cirrhosis, symptoms become more pronounced: jaundice (yellowing of skin and eyes), abdominal swelling from fluid accumulation (ascites), easy bruising, and confusion in severe cases. These signs indicate significant progression and warrant urgent clinical assessment.
Elevated Liver Enzymes on Blood Panel
Mildly elevated ALT and AST on a routine blood panel, particularly in a patient with obesity, type 2 diabetes, or dyslipidemia, is one of the most common ways fatty liver disease is first identified. This finding should never be dismissed without further investigation.
When Should You See
a Doctor for Fatty Liver?
Seek specialist fatty liver disease treatment assessment in Dubai promptly to isolate metabolic drivers and establish accurate fibrosis risk mapping.
Seek Specialist Assessment Without Delay If:
Elevated Liver Enzymes (ALT, AST)
Identified on routine blood testing, particularly alongside obesity, diabetes, or dyslipidaemia. This requires immediate fibrosis risk assessment, not just repeat testing.
Incidentally Identified Fat
Fatty liver identified incidentally on routine imaging should prompt a structured comprehensive metabolic workup rather than being dismissed as a minor finding.
Advanced Liver Signs
Jaundice (yellowing of skin/eyes), abdominal swelling, or easy bruising may indicate advanced liver disease requiring urgent clinical diagnostic assessment.
Indeterminate FIB-4 Score
A FIB-4 or other validated fibrosis screening score in the indeterminate or high-risk range warrants specialist fatty liver disease treatment evaluation.
Type 2 Diabetes Complications
Type 2 diabetes with any abnormal liver test. Diabetic patients have a particularly high fatty liver disease risk profile and should be screened proactively.
High-Risk Family History
A confirmed family history of cirrhosis or liver cancer alongside personal metabolic risk factors warrants early strategic assessment pathways.
If you have known metabolic risk factors (obesity, type 2 diabetes, dyslipidemia) but normal liver enzymes and no symptoms, a baseline liver ultrasound and fibrosis risk calculation is a reasonable proactive step. Specialist fatty liver disease treatment in Dubai ensures the correct screening interval is established and any change is detected early.
Complications of Untreated Fatty Liver
Fatty liver disease is not a benign incidental finding. Left untreated, it can progress through distinct stages toward serious and irreversible liver damage. Early fatty liver disease treatment in Dubai prevents this progression in the majority of patients.
Progression to MASH and Fibrosis
Simple steatosis can progress to metabolic dysfunction-associated steatohepatitis (MASH), where liver inflammation causes ongoing cell damage and scarring (fibrosis). Approximately 20% of patients with MASLD develop MASH, and a proportion of these progress to advanced fibrosis over years if the underlying metabolic drivers are not addressed.
Cirrhosis
Advanced fibrosis can progress to cirrhosis, where extensive scarring permanently disrupts liver structure and function. Cirrhosis from fatty liver disease is now one of the leading indications for liver transplantation globally, having risen dramatically as obesity and diabetes rates have increased.
Liver Cancer
Cirrhosis from fatty liver disease carries a significant risk of hepatocellular carcinoma (liver cancer), and importantly, liver cancer can also arise in fatty liver disease even without cirrhosis being present in some cases. Regular surveillance is recommended for patients with advanced fibrosis or cirrhosis from fatty liver disease.
Cardiovascular Disease
Fatty liver disease is an independent risk factor for cardiovascular disease, beyond the risk conferred by obesity, diabetes, and dyslipidemia alone. Cardiovascular disease, rather than liver disease itself, is the leading cause of death in patients with fatty liver disease, underscoring why fatty liver disease treatment Dubai must address the complete metabolic picture.
Exercise & Weight Management for Fatty Liver
Weight loss and exercise are the most effective treatments for fatty liver disease, with robust evidence demonstrating that even modest, sustained weight loss produces measurable improvement in liver fat content and inflammation. This is the foundation of every fatty liver disease treatment plan in Dubai.
Weight Loss Targets
A 5% reduction in body weight reduces liver fat content. A 7 to 10% reduction improves liver inflammation in MASH. A 10% or greater reduction can improve or even reverse early fibrosis in some patients. These thresholds make structured, sustained weight loss the single most powerful intervention in fatty liver disease treatment in Dubai.
Aerobic Exercise
At least 150 minutes per week of moderate-intensity aerobic exercise (brisk walking, cycling, or swimming) reduces liver fat independently of weight loss through improved insulin sensitivity and fat oxidation within liver cells. In Dubai's climate, gym-based or early-morning and evening outdoor exercises are practical options.
Resistance Training
Resistance training improves insulin sensitivity and supports lean muscle mass during weight loss, helping to preserve metabolic rate. Combining resistance training with aerobic exercise produces greater improvement in liver fat than either alone.
Dietary Pattern
A Mediterranean-style diet, rich in vegetables, whole grains, legumes, and healthy fats with reduced refined carbohydrate and saturated fat intake, has the strongest evidence base for improving fatty liver disease. Reducing fructose intake, particularly from sugar-sweetened beverages, is a specific and impactful dietary change.
How Fatty Liver Disease
Is Diagnosed in Dubai
Diagnosing fatty liver disease requires confirming liver fat content and, critically, assessing the degree of fibrosis present, since fibrosis stage is the primary determinant of long-term prognosis. Dr. Ali Aldibbiat's diagnostic protocol for fatty liver disease treatment in Dubai always includes fibrosis assessment, not just confirmation of fat presence.
Step 1: Liver Function Tests & Metabolic Panel
ALT and AST (often mildly elevated, though can be normal even with significant disease), fasting glucose and HbA1c, full lipid panel, and assessment for other liver disease causes (viral hepatitis, autoimmune liver disease, excess alcohol) to confirm the diagnosis is genuinely metabolic in origin.
Step 2: Liver Ultrasound
The standard initial imaging test identifies fat within the liver as increased echogenicity. Widely available, low cost, and sufficient for initial diagnosis, though it cannot reliably quantify fibrosis stage.
Step 3: FIB-4 Score & Fibrosis Risk Calculation
The FIB-4 score, calculated from age, AST, ALT, and platelet count, is a simple, validated tool for identifying patients at low, indeterminate, or high risk of advanced fibrosis. This calculation is performed at every fatty liver disease treatment Dubai consultation to guide further investigation.
Step 4: Transient Elastography (FibroScan) or MRI Elastography
For patients with indeterminate or high FIB-4 scores, transient elastography measures liver stiffness as a non-invasive surrogate for fibrosis severity. MRI elastography offers even greater precision. Liver biopsy is reserved for cases where non-invasive testing remains inconclusive or diagnostic uncertainty persists.
Fatty Liver Disease Treatment in Dubai
Fatty liver disease treatment in Dubai centers on structured weight loss and exercise, with pharmacological options now available for patients with confirmed MASH and fibrosis. Treating the associated conditions, diabetes, dyslipidemia, and obesity, is integral to managing the liver itself rather than a separate consideration.
Structured Weight Management
Supervised weight loss programs, including dietary counseling and, where appropriate, GLP-1 receptor agonist medications, are increasingly central to fatty liver disease treatment in Dubai. These medications, originally developed for diabetes and obesity, have demonstrated significant improvement in liver fat and MASH resolution in clinical trials.
Glucose & Lipid Optimisation
Tight glycemic control in patients with type 2 diabetes and dyslipidemia treatment reduces the metabolic drivers of liver fat accumulation. Several diabetes medications (pioglitazone, GLP-1 agonists, and SGLT2 inhibitors) have specific evidence for benefit in fatty liver disease beyond their glucose-lowering effect.
Resmetirom for Confirmed MASH with Fibrosis
Resmetirom is the first medication specifically approved for MASH with significant fibrosis, acting on liver thyroid hormone receptors to reduce liver fat and improve fibrosis. It represents an important addition for patients with biopsy- or elastography-confirmed MASH and fibrosis.
Vitamin E for Non-Diabetic MASH
Vitamin E at high doses has evidence for improving liver histology in non-diabetic patients with biopsy-proven MASH, though it is not recommended for patients with diabetes or cirrhosis due to safety considerations in those populations.
Long-Term Clinical Monitoring Protocols
Monitoring of fatty liver disease treatment in Dubai includes repeat FIB-4 scoring and liver function tests every 6 to 12 months, repeat transient elastography for patients with elevated fibrosis risk, and surveillance ultrasound every 6 months for patients with confirmed cirrhosis to screen for liver cancer. Weight, glucose control, and lipid profile are reviewed at every visit as core components of liver health management.
Why Choose Dr. Ali Aldibbiat
for Fatty Liver Disease Treatment?
Dr. Ali Aldibbiat is a consultant endocrinologist providing fatty liver disease treatment in Dubai with over 20 years of specialist clinical experience. His dual FRCP fellowships from the Royal Colleges of London and Edinburgh and his PhD research in metabolic science provide the foundation for managing fatty liver disease as the metabolic condition it fundamentally is.
Fatty liver disease treatment in Dubai is most effective when delivered by a specialist who treats the complete metabolic picture—weight, glucose, and lipids—rather than viewing the liver in isolation. Dr. Ali Aldibbiat's approach integrates fibrosis risk stratification with comprehensive metabolic management, ensuring that treatment addresses both the liver and its underlying drivers simultaneously.
For patients in Dubai with an incidental fatty liver finding, elevated liver enzymes alongside metabolic risk factors, or an elevated fibrosis risk score requiring further evaluation, specialist endocrinology assessment provides the structured pathway from diagnosis through fibrosis staging to evidence-based treatment.
Fibrosis Risk Stratification at Every Consultation
Confirming the presence of fat in the liver is only the first step. Dr. Ali Aldibbiat calculates FIB-4 and arranges elastography where indicated at every fatty liver disease treatment Dubai consultation, ensuring the patients at highest risk of progression are identified and managed appropriately.
Complete Metabolic Management, Not Just Liver Focus
Fatty liver disease treatment in Dubai at Dr. Ali Aldibbiat's clinic addresses diabetes, dyslipidemia, and obesity simultaneously with liver health, reflecting the shared underlying pathology rather than treating each condition in isolation.
Access to Emerging Pharmacological Options
As new medications for MASH and fibrosis become available, including resmetirom and GLP-1 receptor agonists, Dr. Ali Aldibbiat's fatty liver disease treatment in Dubai incorporates the latest evidence-based options for patients with confirmed advanced disease, going beyond lifestyle advice alone where pharmacological treatment is indicated.
Book Your Fatty Liver Disease Consultation in Dubai
Complete metabolic and fibrosis risk assessment. Specialist near me? Jumeirah, Dubai.
Book Appointment ➔Dr. Ali Aldibbiat
- 📍 109 Century Plaza, Jumeirah Beach Rd, Jumeirah 1, Dubai, UAE
- 📞 +971 58 588 2295
- ✉️ a.aldibbiat@draliendo.com
Endocrinologist Available in Dubai, UAE
Ready to Take Control of Your Type 2 Diabetes?
Dr. Ali Aldibbiat offers specialist Type 2 diabetes consultations at his Jumeirah clinic in Dubai, including HOMA-IR assessment, personalized treatment plan, and remission evaluation. No referral required.
📅 Book a Consultation
What Patients Say
I would like to thank Dr. Ali Aldibbiat. He is an exceptional doctor, highly experienced in his specialty, and fully dedicated to his patients' healing.
The hospital has very great services and experienced doctors. Thanks to Dr. Ali Aldibbiat, he knew my issues from the first time. Although I have been to many places, no one could find what I was going through.
I visit Dr. Ali AlDibbiat, the endocrinologist here, who is excellent and very patient. His treatment has significantly improved my diabetes control.
Frequently Asked Questions: Fatty Liver Disease Treatment in Dubai
Fatty liver disease, now called MASLD (metabolic dysfunction associated steatotic liver disease), is a condition where excess fat accumulates in the liver, affecting at least 5% of liver cells, without significant alcohol consumption. It is closely linked to obesity, type 2 diabetes, and metabolic syndrome. It exists on a spectrum from simple fat accumulation through inflammation (MASH) to scarring (fibrosis) and, in advanced cases, cirrhosis. Dr. Ali Aldibbiat provides specialist fatty liver disease treatment dubai with complete metabolic assessment.
Yes, in many cases, particularly in earlier stages. Weight loss of 7 to 10% of body weight improves liver inflammation, and weight loss of 10% or more can improve or reverse early fibrosis in some patients. Even simple steatosis without significant fibrosis can fully resolve with sustained lifestyle change. More advanced fibrosis and cirrhosis are harder to reverse, which is why early fatty liver disease treatment dubai matters significantly.
Fatty liver disease is frequently asymptomatic, particularly in early stages, and is often discovered incidentally on ultrasound or through mildly elevated liver enzymes on routine blood tests. Some patients experience fatigue or mild right upper abdominal discomfort. Symptoms such as jaundice, abdominal swelling, or easy bruising indicate advanced disease and require urgent assessment. Dr. Ali Aldibbiat provides comprehensive fatty liver disease treatment dubai from the first abnormal finding.
Diagnosis begins with liver function tests and an ultrasound to confirm fat presence, followed by a FIB-4 score calculation using age, liver enzymes, and platelet count to assess fibrosis risk. For patients with indeterminate or elevated risk, transient elastography (FibroScan) or MRI elastography provides non-invasive fibrosis staging. This complete workup, not just fat confirmation, is standard for fatty liver disease treatment dubai.
Yes, it can be very serious. Untreated fatty liver disease can progress through inflammation (MASH) to fibrosis, cirrhosis, and in some cases liver cancer. Fatty liver disease is also an independent risk factor for cardiovascular disease, which is actually the leading cause of death in these patients, not liver failure itself. Early fatty liver disease treatment dubai substantially reduces these risks through structured metabolic management.
A consultant endocrinologist is well placed to manage fatty liver disease in Dubai given its fundamentally metabolic nature, particularly when diabetes, obesity, or dyslipidaemia are also present. Dr. Ali Aldibbiat provides specialist fatty liver disease treatment dubai at 109 Century Plaza, Jumeirah Beach Road, Jumeirah 1, covering fibrosis risk assessment, weight management, and the complete metabolic picture. Book at /contact/book-appointment/ or call +971 58 588 2295.
Dr. Ali Aldibbiat’s Endocrinology Clinic in Dubai, UAE
Dr. Ali Aldibbiat runs an endocrinology clinic at 109 Century Plaza, Jumeirah Beach Road, Jumeirah 1, Dubai, UAE. He also sees patients at Mediclinic City Hospital, Dubai. Patients from across Dubai, Abu Dhabi, Sharjah, and the wider UAE and Gulf region travel to his Jumeirah clinic for specialist endocrine and metabolic care. If you are searching for the best endocrinologist near me in Dubai, no referral is required; book directly at draliendo.com.